gavin
Topics Engaged In
-
- Topic
- Voices
- Posts
- Last Post
-
-
Clinical and molecular features of responders to PD-1 blockade for patients with
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
NTRK gene fusions in bilio-pancreatic cancers.
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Personalized multimodality therapy (ICT) with immune checkpoint inhibitors (ICI)
Started by:
in: Chemotherapy & More
- 1
- 1
- 4 years, 3 months ago
-
In-hospital outcomes of splanchnic vein thrombosis including Budd Chiari syndrom
Started by:
in: Adverse Reactions & Side Effects
- 1
- 1
- 4 years, 3 months ago
-
Lipocalin 2 – Devil or Angel? A pan cancer study.
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Phase I study (PAYLOAD) of RRx-001 + irinotecan in patients with advanced solid
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
BRAF mutation in Chinese biliary tract cancer patients.
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Exceptional sustained responses to ipilimumab/nivolumab (ipi/nivo) in patients (
Started by:
in: Chemotherapy & More
- 1
- 1
- 4 years, 3 months ago
-
A phase I study of the novel immunotoxin, MT-5111, in subjects (subj) with HER-2
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Hepatic arterial infusion (HAI) chemotherapy via the medtronic pump-assessing do
Started by:
in: Chemotherapy & More
- 1
- 1
- 4 years, 3 months ago
-
PD-L1 expression as a prognostic marker in patients with advanced biliary tract
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
First-in-human (FIH) phase I study of GST-HG161, a potent and highly selective c
Started by:
in: Clinical Trials
- 1
- 1
- 4 years, 3 months ago
-
Impact of tumor histology and socioeconomic factors on survival of patients suff
Started by:
in: New Developments
- 1
- 1
- 4 years, 3 months ago
-
Clinical and molecular features of responders to PD-1 blockade for patients with